Cargando…

Persistence of SARS-CoV-2 IgG Antibody Response among South African Adults: A Prospective Cohort Study

This study assesses the durability of severe acute respiratory coronavirus-2 (SARS-CoV-2) anti-nucleocapsid (anti-N) immunoglobulin G (IgG) after infection and examines its association with established risk factors among South African healthcare workers (HCWs). Blood samples were obtained from 390 H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adeniyi, Oladele Vincent, Durojaiye, Oyewole Christopher, Masilela, Charity
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302206/ https://www.ncbi.nlm.nih.gov/pubmed/37376457 http://dx.doi.org/10.3390/vaccines11061068

Ejemplares similares

Prevalence, patterns and determinants of dyslipidaemia among South African adults with comorbidities
por: Masilela, Charity, et al.
Publicado: (2022)

Single Nucleotide Polymorphisms in Amlodipine-Associated Genes and Their Correlation with Blood Pressure Control among South African Adults with Hypertension
por: Masilela, Charity, et al.
Publicado: (2022)

Cross-sectional study of prevalence and determinants of uncontrolled hypertension among South African adult residents of Mkhondo municipality
por: Masilela, Charity, et al.
Publicado: (2020)

Genomic Association of Single Nucleotide Polymorphisms with Blood Pressure Response to Hydrochlorothiazide among South African Adults with Hypertension
por: Masilela, Charity, et al.
Publicado: (2020)

Factors associated with glycemic control among South African adult residents of Mkhondo municipality living with diabetes mellitus
por: Masilela, Charity, et al.
Publicado: (2020)

Single Nucleotide Polymorphisms Associated with Metformin and Sulphonylureas’ Glycaemic Response among South African Adults with Type 2 Diabetes Mellitus
por: Masilela, Charity, et al.
Publicado: (2021)

Cross-sectional study of the association of 5 single nucleotide polymorphisms with enalapril treatment response among South African adults with hypertension
por: Masilela, Charity, et al.
Publicado: (2021)

Long-Term Persistence of Anti-SARS-COV-2 IgG Antibodies
por: Yousefi, Zahra, et al.
Publicado: (2022)

Healthcare workers’ perceptions of sexual violence during the COVID-19 pandemic in the Eastern Cape
por: Kwinana, Nolundi, et al.
Publicado: (2023)

Persistence of IgG response to SARS-CoV-2
por: Duysburgh, Els, et al.
Publicado: (2021)

SARS-CoV-2 IgG and IgA antibody response is gender dependent; and IgG antibodies rapidly decline early on
por: Korte, Wolfgang, et al.
Publicado: (2021)

Persistence of IgG COVID-19 antibodies: A longitudinal analysis
por: Carvalho, Álvaro, et al.
Publicado: (2023)

Association of dengue infection with anti-alpha-gal antibodies, IgM, IgG, IgG1, and IgG2
por: Olajiga, Olayinka M., et al.
Publicado: (2022)

IgG SARS-CoV-2 Antibodies Persist at Least for 10 Months in Patients on Hemodialysis
por: Dudreuilh, Caroline, et al.
Publicado: (2021)

SARS-COV-2 IgG and IgM Antibodies in Cancer Patients
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Specific Antibody Deficiency in Adult Patients With IgG or IgG Subclass Deficiency
por: Kim, Joo-Hee, et al.
Publicado: (2020)

Performance of the Abbott SARS-CoV-2 IgG serological assay in South African 2 patients
por: Jugwanth, Sarika, et al.
Publicado: (2022)

Serologic Tests of IgG and IgM Antibodies and IgG Avidity for Diagnosis of Ocular Toxoplasmosis
por: Rahimi-Esboei, Bahman, et al.
Publicado: (2018)

Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies
por: Takahashi, Maika, et al.
Publicado: (2022)

Patterns and persistence of SARS-CoV-2 IgG antibodies in Chicago to monitor COVID-19 exposure
por: Demonbreun, Alexis R., et al.
Publicado: (2021)

Patterns and persistence of SARS-CoV-2 IgG antibodies in Chicago to monitor COVID-19 exposure
por: Demonbreun, Alexis R., et al.
Publicado: (2021)

Persistence of Anti-SARS-CoV-2 Spike IgG Antibodies Following COVID-19 Vaccines
por: Alharbi, Naif Khalaf, et al.
Publicado: (2022)

Subclasses of allergen-specific IgG: Serum IgG2 and IgG3 levels are not predicted by IgG1/IgG4 levels
por: MacGlashan, Donald, et al.
Publicado: (2021)

Pulmonary manifestations of IgG4‑related disease in a South African patient
por: Cilliers, J D, et al.
Publicado: (2021)

Role of specific IgE, IgG and IgG4 antibodies to corn dust in exposed workers
por: Park, Hae-Sim, et al.
Publicado: (1998)

SARS-CoV-2 IgG antibody responses in New York City
por: Reifer, Josh, et al.
Publicado: (2020)

Generation and persistence of S1 IgG and neutralizing antibodies in post-COVID-19 patients
por: Guzmán-Martínez, Oscar, et al.
Publicado: (2021)

Screening for IgG4-type anti-nuclear antibodies in IgG4-related disease
por: Kiyama, Kazuhiro, et al.
Publicado: (2015)

IgG Antibody Response to SARS-CoV-2 Infection and Viral RNA Persistence in Patients on Maintenance Hemodialysis
por: De Vriese, An S., et al.
Publicado: (2020)

Performance of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies in South Africa
por: Gededzha, Maemu P., et al.
Publicado: (2021)

Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG
por: Sapkal, Gajanan, et al.
Publicado: (2020)

SARS-COV-2 IgG antibody response in pregnant women at delivery
por: Tsatsaris, Vassilis, et al.
Publicado: (2021)

The antiinflammatory activity of IgG: the intravenous IgG paradox
por: Nimmerjahn, Falk, et al.
Publicado: (2007)

Hinge length contributes to the phagocytic activity of HIV-specific IgG1 and IgG3 antibodies
por: Chu, Thach H., et al.
Publicado: (2020)

Insights into the IgG heavy chain engineering patent landscape as applied to IgG4 antibody development
por: Dumet, Christophe, et al.
Publicado: (2019)

Serum IgG4 levels outperform IgG4/IgG RNA ratio in differential diagnosis of IgG4-related disease
por: Schulte, Lucas A., et al.
Publicado: (2020)

Persistent Lymphadenopathy due to IgG4-Related Disease
por: Smith, Benjamin, et al.
Publicado: (2012)

Seroprevalence of SARS-CoV-2 specific IgG antibodies among eye care workers in South India
por: Siva Ganesa Karthikeyan, Rajapandian, et al.
Publicado: (2021)

A Prospective Study on Rapidly Declining SARS‐CoV‐2 IgG Antibodies Within One to Three Months of Testing IgG Positive: Can It Lead to Potential Reinfections?
por: Nag, Deb Sanjay, et al.
Publicado: (2020)

Effectiveness of Strongyloides Recombinant IgG Immunoreactive Antigen in Detecting IgG and IgG4 Subclass Antibodies for Diagnosis of Human Strongyloidiasis Using Rapid Immunochromatographic Tests
por: Boonroumkaew, Patcharaporn, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_osnrcgf6qb1l77ik2lq5ovp3vp